Title |
Case report: a thiazide diuretic to treat polyuria induced by tolvaptan
|
---|---|
Published in |
BMC Nephrology, July 2018
|
DOI | 10.1186/s12882-018-0957-7 |
Pubmed ID | |
Authors |
Bart J. Kramers, Maatje D. A. van Gastel, Esther Meijer, Ron T. Gansevoort |
Abstract |
Currently, the vasopressin V2 receptor antagonist tolvaptan is the only available treatment for autosomal dominant polycystic kidney disease (ADPKD), but there are tolerability issues due to aquaretic side-effects such as polyuria. A possible strategy to ameliorate these side-effects may be addition of a thiazide diuretic, this is an established treatment in nephrogenic diabetes insipidus, a condition where vasopressin V2 receptor function is absent. We describe a 46-year-old male ADPKD-patient, who was prescribed tolvaptan, which caused polyuria of around 5 l per day. Hydrochlorothiazide was added to treat hypertension, which resulted in a marked decrease in urine production. While using tolvaptan, rate of eGFR decline was - 1.35 mL/min/1.73m2 per year, whereas after hydrochlorothiazide was initiated this was - 3.97 mL/minute/1.73m2 per year. This case report indicates that while addition of hydrochlorothiazide may improve tolerability of vasopressin V2 receptor antagonists, co-prescription should only be used with great scrutiny as it may decrease tolvaptan effect on rate of ADPKD disease progression. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 11% |
United Kingdom | 1 | 11% |
Australia | 1 | 11% |
Unknown | 6 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 56% |
Practitioners (doctors, other healthcare professionals) | 4 | 44% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 26 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 4 | 15% |
Researcher | 3 | 12% |
Student > Doctoral Student | 2 | 8% |
Student > Bachelor | 2 | 8% |
Student > Ph. D. Student | 2 | 8% |
Other | 4 | 15% |
Unknown | 9 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 31% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 8% |
Biochemistry, Genetics and Molecular Biology | 2 | 8% |
Psychology | 2 | 8% |
Economics, Econometrics and Finance | 1 | 4% |
Other | 2 | 8% |
Unknown | 9 | 35% |